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58 Objective
59 To examine the risk of self-harm in rheumatological conditions 
60 Methods 
61 Retrospective cohort study using data from the Clinical Practice Research Datalink. Patients 
62 with ankylosing spondylitis, fibromyalgia, osteoarthritis or rheumatoid arthritis were 
63 identified between 1990–2016 and matched to patients without these conditions. Incident 
64 self-harm was defined by medical record codes following a rheumatological diagnosis. 
65 Incidence rates (per 10,000 person-years(PY)) were reported for each condition, both 
66 overall and year-on-year(2000-2016). Cox regression analysis determined risk (hazard 
67 ratios(HR), 95% confidence interval(CI)) of self-harm for each rheumatological cohort 
68 compared to the matched unexposed cohort. Initial crude analysis was subsequently 
69 adjusted and stratified by age and gender. Due to non-proportionality over time, 
70 osteoarthritis was also stratified by disease duration(<1 year, ≥1-<5 years, ≥5-<10 years, 
71 ≥10 years).
72 Results
73 Incidence of self-harm was highest in patients with fibromyalgia (25.12 (95%CI 22.45,28.11) 
74 per 10,000 PY) and lowest for osteoarthritis (6.48 (6.20, 6.76)). There was a crude 
75 association with each rheumatological condition and self-harm, except for ankylosing 
76 spondylitis. Though attenuated, these associations remained after adjustment for 
77 fibromyalgia (HR 2.06(95%CI 1.60,2.65)), rheumatoid arthritis (1.59(1.20,2.11)) and 
78 osteoarthritis (1-<5years: 1.12 (1.01,1.24); ≥5-<10 years: 1.35 (1.18,1.54)). Age and gender 
79 were weak effect modifiers for these associations. 
80 Conclusions
81 Primary care patients with fibromyalgia, osteoarthritis or rheumatoid arthritis (but not 
82 ankylosing spondylitis) are at increased risk of self-harm compared to people without these 
83 rheumatological conditions. Clinicians need to be aware of the potential for self-harm in 
84 patients with rheumatological conditions (particularly fibromyalgia), explore mood and risk 






























106 Significant findings 
107  Patients with fibromyalgia, osteoarthritis or rheumatoid arthritis are at increased risk of 
108 self-harm.
109  Age and gender do not act as strong effect modifiers in the relationship between these 
110 rheumatological conditions and self-harm






























132 Prevention of self-harm, a key risk factor for suicide, is an international public health priority 
133 (1). However, data from the UK between 2001 to 2013 showed a significant rising trend in 
134 primary care consultations for self-harm for men and women (2). A potential approach to 
135 preventing self-harm is the targeting of high-risk groups, with the World Health 
136 Organization (WHO) recommending that healthcare professionals assess the potential for 
137 self-harm in patient groups with symptoms of chronic pain and depression (3). Though these 
138 factors can apply to patients with rheumatological conditions, it remains unclear whether 
139 patients in these disease groups are at an increased risk of self-harm.
140
141 Our interest lies in examining and comparing the risk of self-harm in specific 
142 rheumatological conditions (ankylosing spondylitis, fibromyalgia, osteoarthritis and 
143 rheumatoid arthritis). These are some of the most prevalent rheumatological conditions 
144 with known relationships to chronic pain and depression. Poor mental health, especially a 
145 history of a depressive disorder, is a strong risk factor for self-harm (4) and comorbid 
146 depression is frequently experienced by patients with these common rheumatological 
147 conditions, to varying degrees (5-9). Although pain is on the causal pathway for depression, 
148 pain is itself an independent risk factor for self-harm (10) and is commonly experienced by 
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151 Previous research into the role of a range of chronic health conditions on the risk of self-
152 harm has shown conflicting findings (12-15). However, investigation into the role of 
153 rheumatological conditions as risk factors for self-harm is currently very limited, despite 
154 these conditions being among the leading causes of disability worldwide (16). Webb et al 
155 reported an initial unadjusted increased risk of self-harm in patients with osteoarthritis, but 
156 this association was not retained after adjustment (12). Singhal et al did find an increased 
157 relative risk (RR) of self-harm for patients with inflammatory polyarthropathies (RR 1.4 
158 (1.3–1.4) after the first year since diagnosis, but this group contained a wide mix of 
159 rheumatological conditions (ICD-10 code: (M05–M09, M12–M14)) limiting the clinical 
160 usefulness of such information (14). Our aim was to examine and compare the risk of self-
161 harm in several rheumatological conditions from a primary care population over time and 
162 consider the role of age and gender on such risk. 
163
164 Patients and Methods
165 Study design
166 We undertook a matched retrospective cohort study using Read-coded patient consultation 
167 data (the clinical coding system used in UK primary care) from the Clinical Practice Research 
168 Datalink (CPRD), a database of anonymised primary care records covering around 7% of the 
169 UK population (17). This provides both coded consultation and prescription data and is 
170 representative of the UK population, with regards to age, sex and ethnicity (17).
171
172 Study Population
173 We identified patients aged ≥18 years with one of four rheumatological conditions 
174 (ankylosing spondylitis, fibromyalgia, osteoarthritis or rheumatoid arthritis) between 1st 
175 January 1990 and 31st December 2016. Each exposed cohort was identified by specified 
176 Read codes, identified and refined from an internal code list repository 
177 (www.keele.ac.uk/mrr) and assigned an index date corresponding to the date of their 
178 diagnosis. Where a patient had consulted for more than one of the rheumatological 
179 conditions of interest, they were placed into the rheumatological cohort for which they had 
180 first consulted. A single matched unexposed cohort was constructed to be a comparison 
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182 without a previous coded diagnosis of the rheumatological conditions of interest in their 
183 medical record, but no further exclusion was made based on the presence of other chronic 
184 disease. Cases were grouped by 10-year age range and gender and then within these 
185 categories’ frequency matched to unexposed patients. Each control was assigned a pseudo-
186 index date, generated at random from between their 18th birthday and the end of the study. 
187 All individuals were subsequently examined for a self-harm Read code, based on the Read 
188 code list used in previous CPRD research (2) (Code list available at www.keele.ac.uk/mrr 
189 upon request). Patients with a self-harm code prior to index date were excluded and 
190 incidence based only on the first self-harm code reported post-rheumatological diagnosis.
191
192 Statistical Analysis
193 Descriptive statistics were initially used to characterise the sample of each rheumatological 
194 condition, including age, gender, practice-level deprivation, BMI, smoking status, alcohol 
195 consumption and previous diagnosis for anxiety and/or depression (the latter four defined 
196 by the closest value recorded before the index date). Incidence rates of self-harm per 10,000 
197 person-years (PY) were determined for each rheumatological condition from 01/01/1990 to 
198 31/12/2016 and year-on-year incidence trends were reported for 01/01/2000 to 
199 31/12/2016 (reduced time-period used due to low incidence in earlier years). Patients 
200 contributed data after the latest of three events: (1) the study start date, (2) the date they 
201 registered at a participating practice, plus 6 months or (3) the date at which the practice was 
202 adjudged to reach internal quality standards, known as the ‘up-to-standard’ date. 
203
204 Using Cox proportional-hazards regression analysis over the full time-period (1990-2016), 
205 crude hazard ratios (HR) were initially reported with 95% confidence intervals (CIs) to 
206 examine the association between the presence of each of the four rheumatological 
207 conditions and the subsequent incidence of self-harm compared to the matched unexposed 
208 cohort. Adjusted analysis was then undertaken, accounting for age, gender, practice-level 
209 deprivation, BMI, smoking status, alcohol consumption, anxiety and depression. Cases with 
210 missing data for smoking, BMI and alcohol consumption were included within analysis using 
211 a missing category approach. Imputation was not considered sensible in this case, as data 
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213 each model using Schoenfeld’s residuals. Where variables showed evidence of non-
214 proportionality, they were included as time varying covariates. Further analyses were 
215 conducted for each rheumatological cohort, stratifying by median age of the relevant 
216 exposed cohort and gender. We defined our dichotomized age subgroups as “younger” or 
217 “older” patients. This study was approved by the CPRD Independent Scientific Advisory 
218 Committee (reference number 18_018R3). Data were analyzed with Stata software (version 





224 The number of cases in each rheumatological condition group identified were: ankylosing 
225 spondylitis 10,484, fibromyalgia 17,546; osteoarthritis 410,384 and rheumatoid arthritis 
226 23,205, with a matched unexposed cohort of the same size for each condition. Patient 
227 cohorts with fibromyalgia, osteoarthritis or rheumatoid arthritis were predominantly female 
228 (85.5%, 59.5% & 66.7% respectively) and the mean age across the four condition cohorts 
229 (similar in their unexposed cohorts) ranged from the youngest of 47 years (fibromyalgia) to 
230 the oldest at 65 years (osteoarthritis) (Table 1). 
231
232 Incidence of self-harm in rheumatological cohorts 
233 Incidence of self-harm was highest in the fibromyalgia cohort at 25.12 (95%CI 22.45, 28.11) 
234 per 10,000 PY, but lower at 11.37 (9.37, 13.81) for ankylosing spondylitis, 9.70 (8.32, 11.29) 
235 for rheumatoid arthritis and 6.48 (6.20, 6.76) for osteoarthritis (Table 2). Over a 16-year 
236 period (2000-2016), and despite fluctuations, the year-on-year incidence rates of self-harm 
237 across each rheumatological condition changed little, with incidence rates in 2016 similar to 
238 those in 2000 (Figure 1).
239
240 Risk of self-harm in rheumatological conditions
241 The risk of self-harm in patients with osteoarthritis was not proportional over the study 
242 period. As such, risk in this condition group was examined over four separate time-periods 
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244 crude association between fibromyalgia (HR 3.01 (95%CI 2.42, 3.76)), rheumatoid arthritis 
245 (1.72 (1.34, 2.22)) and for the majority of categories of osteoarthritis patients (excluding 
246 those with a disease duration of less than 1 year (1.07 (0.90, 1.26)) and subsequent self-
247 harm compared to their matched unexposed counterparts. There was no association 
248 between ankylosing spondylitis and self-harm compared to the unexposed matched cohort 
249 (1.21 (0.90, 1.64)). 
250
251 After adjustment, the association in each cohort was attenuated. Patients with fibromyalgia 
252 remained twice as likely to self-harm as those without a rheumatological condition and 
253 rheumatoid arthritis patients had an increased self-harm risk of 59%. The increased risk of 
254 self-harm in osteoarthritis with a disease duration of 1-<5years and ≥5-<10 years was 12% 
255 and 35% respectively; however, patients with osteoarthritis for ≥10 years no longer had a 
256 significant risk of self-harm (1.17 (0.98, 1.40)) (Table 2).
257
258 Age-specific risk of self-harm in rheumatological conditions
259 After stratifying by median age, we found there to be a similar association between the risk 
260 of self-harm across the younger and older strata for the rheumatoid arthritis cohort. 
261 However, this association was only statistically significant for the younger cohort (Younger: 
262 1.67 (1.18, 2.36), Older: (1.52 (0.92, 2.52)). In the fibromyalgia cohort, both age categories 
263 experienced a significant increase in risk of self-harm with older patients experiencing a 
264 slightly greater risk (Younger: 2.28 (1.66, 3.13), Older 2.58 (1.67, 3.99)). There was a 
265 somewhat mixed picture for osteoarthritis, with some younger patients seeing an increase in 
266 risk (1-<5years: 1.18 (1.03, 1.34); ≥5-<10 years: 1.34 (1.13, 1.58), as did older patients with 
267 osteoarthritis (1.22 (1.07, 1.38), across all disease durations).  There remained no increased 
268 risk of self-harm in patients with ankylosing spondylitis when stratified by age (Table 3).
269
270 Gender-specific risk of self-harm in rheumatological conditions
271 There were similar levels of increased risk of self-harm across the genders in those with 
272 osteoarthritis, rheumatoid arthritis or fibromyalgia compared to those without a 
273 rheumatological condition. Men and women who had had osteoarthritis for between ≥5-<10 
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275 though the risk estimates for men with rheumatoid arthritis or fibromyalgia were similar to 
276 that of women with the same condition, the increase was not statistically significant in either 




281 We found that primary care patients with rheumatological conditions of fibromyalgia, 
282 rheumatoid arthritis or osteoarthritis are at increased risk of self-harm compared to 
283 matched unexposed patients, that this risk varies across the three conditions, but that age 
284 and gender are weak effect modifiers. In contrast there was no association between 
285 ankylosing spondylitis and self-harm. Finally, the year-on-year incidence of self-harm in 
286 these patient groups remained relatively consistent from 2000 to 2016.
287
288 Overall, patients with fibromyalgia had the greatest risk of self-harm with a 2-fold increase 
289 compared to the unexposed cohort. This propensity to self-harm was greater than that seen 
290 for the rheumatoid arthritis and osteoarthritis cohorts and may relate to different effects of 
291 similar mechanisms. Patients with fibromyalgia have been shown to experience more 
292 depression (6, 7, 20) and poorer health outcomes, particularly bodily pain (21) and fatigue 
293 (22), than patients with osteoarthritis and rheumatoid arthritis.  Furthermore, in contrast to 
294 osteoarthritis and rheumatoid arthritis, psychological factors play a major role in the origin 
295 of this disorder as both physical and childhood trauma are associated with fibromyalgia and 
296 self-harm (4, 23).  Though the risk of self-harm in different rheumatological conditions has 
297 not been previously described, a meta-analysis by Li et al did find the prevalence of suicidal 
298 ideation (of which self-harm is a risk factor (24)) to be greater in patients with fibromyalgia 
299 compared to the other rheumatological conditions (systemic lupus erythematosus and 
300 osteoarthritis) (25). This suggests the greatest risk we observed in patients with 
301 fibromyalgia is plausible. 
302
303 Our initial findings on osteoarthritis were in-line with those of Webb et al, who examined the 
304 risk of self-harm in several physical illnesses using CPRD (12) and found an unadjusted 
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306 found that after adjustment the risk of self-harm remained for certain disease duration 
307 categories. In our study, the risk remained increased in those having had osteoarthritis for 
308 between 1 and 10 years. Our contrasting findings to Webb et al are potentially due to our 
309 increased sample size from a much longer time-period of the CPRD, and thus greater 
310 statistical power. However, it is clear that the risk of self-harm in osteoarthritis is relatively 
311 modest, especially compared to fibromyalgia and rheumatoid arthritis. This may reflect a 
312 different experience in terms of pain duration, frequency and location; osteoarthritis is 
313 typically a more localised pain condition, unlike the generalized pain and systemic 
314 symptoms caused by fibromyalgia and rheumatoid arthritis, and therefore may have less 
315 impact on patients’ lives leading to self-harm behaviour. Furthermore, the violation of the 
316 proportional hazards assumption in our study suggests that the risk of self-harm is 
317 influenced by disease duration, this may have been masked in the study of Webb et al (12) 
318 where data were from a case-control study and so the effect of disease duration could not be 
319 assessed. Though there is mixed evidence around the association between disease duration 
320 and progression of osteoarthritis (26), we found that those with newly diagnosed 
321 osteoarthritis (≤1 year) or those with long-standing disease (≥10 years) were not at 
322 significantly increased risk of self-harm. This could be due to patients with a recent 
323 diagnosis not yet having a prolonged negative experience of osteoarthritis, which could be a 
324 contributing factor to self-harm, or those with very long-standing osteoarthritis having 
325 developed coping mechanisms (27). 
326
327 Despite crude analysis demonstrating an initial association, adjusted analysis did not show 
328 ankylosing spondylitis to be a risk factor for self-harm. These findings may be related to this 
329 cohort having the greatest proportion of men, with a reduced incidence of self-harm 
330 compared to women (2). However, our matching, adjustment and stratification should have 
331 countered for the majority of confounding for gender. Though not examining self-harm, Wu 
332 et al. found no association between ankylosing spondylitis and subsequent suicide ideation 
333 or attempt (9). Although Wu et al., used a different group of patients, their sample was from 
334 a large population-based cohort which suggests our findings are conceivable and not just an 
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337 Overall, we found age and gender to be weak effect modifiers of the relationship between all 
338 rheumatological cohorts and subsequent self-harm. For patients with fibromyalgia or 
339 rheumatoid arthritis, we found little difference in the strength of association between 
340 younger and older, or male and female patients and the subsequent risk of self-harm. 
341 However, this finding is tempered by relatively small participant numbers, which meant that 
342 the association was not statistically significant for men with fibromyalgia or rheumatoid 
343 arthritis and older patients with rheumatoid arthritis. Therefore, further study on the role of 
344 these factors is required to clarify this association. 
345
346 Our findings suggest that primary care clinicians, rheumatologists and allied health 
347 professionals need to be especially aware of the potential for self-harm in people with 
348 fibromyalgia and rheumatoid arthritis, exploring mood and risk, and offering appropriate 
349 support and management. Interventions to reduce this serious comorbidity in 
350 rheumatological patients are important because, as our incident data show, little has 
351 changed in the proportion of patients who self-harm in recent years. 
352
353 With regard to the strengths and limitations of our work, this is the first study to examine 
354 several rheumatological conditions as risk factors for incident self-harm. Our use of a large 
355 UK primary care dataset has allowed us to examine the incidence of self-harm over a 26-year 
356 time-period, year-on-year incidence trends over a 16-year time-period and examine the role 
357 of age and gender on risk of self-harm. Our analysis also takes account of clinically recorded 
358 depression, a key risk factor for self-harm. However, several limitations to our work need to 
359 be considered. Across these rheumatological conditions of interest, pain is likely to be an 
360 important contributory factor in the risk of self-harm (28), but could not be determined from 
361 consultation record data. Furthermore, it remains unclear to what extent use of medications 
362 influence the risk of self-harm, though the potential causal mechanism of such medications 
363 means this would be difficult to disentangle. We also found large proportions of missing data 
364 for BMI, smoking and alcohol consumption within the CPRD dataset, particularly in the 
365 unexposed patients. As such data is not “missing at random”, we were unable to impute for 
366 these variables. However, we included missing data as a separate category in the Cox model 
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368 may also be some residual confounding. Firstly for psychological comorbidities, though our 
369 adjustment for anxiety and depression will have covered the majority of these, and secondly 
370 for additional rheumatological comorbidities, where patients went on to develop a further 
371 rheumatological condition of interest (most likely the common condition of OA) after they 
372 had been grouped into a cohort based on their first rheumatological consultation. However, 
373 the small increased risk of self-harm in patients with OA that we found would suggest that 
374 any confounding would have a minimal impact on the risk experienced by those with the 
375 other rheumatological conditions of interest. Our original intention within this analysis had 
376 also been to examine the risk of suicide, as well as self-harm, in these rheumatological 
377 conditions. However, available samples were too small to conduct such analysis. The 
378 available sample also proved problematic when stratifying by gender. As the majority of 
379 included participants were female, stratification by gender lead to small numbers of events 
380 in the male cohorts (e.g. only 35 incidents of self-harm in men with fibromyalgia). However, 
381 stratification remains justified, as it highlights the role of age and gender. 
382
383 In conclusion, patients with rheumatological conditions have increased risk of self-harm 
384 compared to matched unexposed patients, but age and gender do not act as strong effect 
385 modifiers. The incidence of self-harm in these conditions has remained relatively consistent 
386 over the last decade and a half and therefore clinicians should be vigilant, explore mood, 









396 This study is based in part on data from the Clinical Practice Research Datalink obtained 
397 under licence from the UK Medicines and Healthcare products Regulatory Agency. The data 
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399 interpretation and conclusions contained in this study are those of the author/s alone in ALL 
400 publications.  
401
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Table 1: Characteristics of patients with rheumatological conditions and their matched cohorts (1990-2016)
Factor Ankylosing Spondylitis Fibromyalgia Osteoarthritis Rheumatoid Arthritis
Exposed (%) Unexposed (%) Exposed (%) Unexposed (%) Exposed (%) Unexposed (%) Exposed (%) Unexposed (%)
N 10,484 10,484 17,546 17,546 410,384 410,384 23,205 23,205
Mean age at index (SD) 46.9 (15.6) 46.6 (15.9) 46.9 (12.1) 46.6 (12.7) 64.6 (12.7) 64.2 (13.2) 56.7 (15.2) 56.4 (15.6)
Males 4,376 (41.7) 4,376 (41.7) 2,552 (14.5) 2,552 (14.5) 166,241 (40.5) 166,241 (40.5) 7,728 (33.3) 7,728 (33.3)
Median years follow-up (IQR) 7.4 (3.8. 12.2) 5.3 (2.7, 10.6) 5.8 (3.0, 9.9) 5.7 (2.7, 11.3) 6.8 (3.6, 11.0) 5.9 (2.9, 11.0) 6.2 (3.1, 10.5) 5.9 (2.8, 11.2)
Deprivation status
Q1 (Least deprived) 1,986 (18.9) 1,917 (18.3) 3,002 (17.1) 3,218 (18.3) 72,018 (17.6) 73,347 (17.9) 3,774 (16.3) 4,186 (18.1)
Q2 1,806 (17.2) 1,782 (17.0) 2,960 (16.9) 3,227 (18.4) 71,941 (17.5) 72,068 (17.5) 4,070 (17.5) 4,042 (17.4)
Q3 2,109 (20.1) 2,190 (20.9) 3,337 (19.0) 3,571 (20.4) 79,179 (19.3) 85,833 (20.8) 4,752 (20.5) 4,824 (20.8)
Q4 1,925 (18.4) 2,259 (21.5) 3,786 (21.6) 3,766 (21.5) 85,826 (20.9) 90,589 (22.1) 4,892 (21.1) 5,041 (21.7)
Q5 (Most deprived) 2,658 (25.4) 2,336 (22.3) 4,461 (25.4) 3,764 (21.4) 101,420 (24.7) 89,047 (21.7) 5,717 (24.6) 5,112 (22.0)
BMI (kg/m2)
Underweight (<18.5) 164 (1.5) 123 (1.2) 286 (1.6) 218 (1.2) 3,013 (0.7) 3,587 (0.9) 389 (1.7) 234 (1.0)
Healthy weight (<18.5-
24.9)
3,707 (35.4) 2,294 (21.9) 5,602 (31.9) 4,371 (24.9) 99,869 (24.3) 79,731 (19.4) 7,491 (32.3) 4,920 (21.2)
Overweight (25.0-29.9) 2,800 (26.7) 1,587 (15.1) 4,983 (28.4) 2,638 (15.0) 136,070 (33.2) 72,724 (17.7) 6,600 (28.4) 3,960 (17.1)
Obese (>30.0) 1,595 (15.2) 886 (8.4) 4,817 (27.5) 1,747 (10.0) 104,776 (25.5) 37,063 (9.2) 4,474 (19.3) 2,137 (9.2)
Missing 2,218 (21.2) 5,594 (53.4) 1,858 (10.6) 8,572 (48.9) 66,656 (16.3) 216,739 (52.8) 4,251 (18.3) 11,954 (51.5)
Smoking
Never/Ex smoked 6,680 (63.7) 4,212 (40.2) 12,163 (69.3) 7,696 (43.9) 308,795 (75.2) 170,633 (41.6) 15,332 (66.1) 9,660 (41.6)
Current smoker 2,540 (24.2) 1,494 (14.2) 4,636 (26.4) 2,416 (13.8) 63,869 (15.6) 48,963 (11.9) 5,566 (24.0) 3,0.37 (13.1)
Missing 1,264 (12.1) 4,778 (45.6) 747 (4.3) 7,434 (42.4) 37,720 (9.2) 190, 788 (46.5) 2,307 (9.9) 10,508 (45.3)
Alcohol consumption
Never/Ex-drinker 1,493 (14.2) 942 (9.0) 4,104 (23.4) 1,735 (9.9) 72,098 (17.6) 42,065 (10.2) 4,229 (18.2) 2,225 (9.6)
Current 1-9 4,923 (47.0) 3,000 (28.6) 9,355 (53.3) 5,824 (33.2) 200,504 (48.9) 116,325 (28.4) 11,178 (48.2) 6,891 (29.7)
Current >=10 1,6223 (15.5) 869 (8.5) 1,692 (9.6) 1,236 (7.0) 66,935 (16.3) 32,979 (8.0) 3,120 (13.5) 1,891 (8.1)
Missing 2,445 (23.3) 5,646 (53.9) 2,395 (13.7) 8,751 (49.9) 70,847 (17.2) 219,016 (53.4) 4,678 (20.1) 12,198 (52.6)
Anxiety 1,757 (16.8) 879 (8.4) 5,944 (33.9) 1,865 (10.6) 67,894 (16.5) 36,568 (8.9) 3,385 (14.6) 2,229 (9.6)
Depression 2,356 (22.5) 1,263 (12.1) 8,784 (50.1) 2,786 (15.9) 90,354 (22.0) 51,631 (12.6) 5,035 (21.7) 3,064 (13.2)
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Table 2: Risk of self-harm associated with each rheumatological condition 
*adjusted for age, BMI, smoking status, alcohol consumption, anxiety, depression and practice-level deprivation. Bold = statistically significant (p<=0.05). 
Exposed Unexposed Hazard ratios (95% CI)
Condition n Incidence rate, per 
10,000 (95% CI)




Ankylosing Spondylitis 102 11.37 (9.37, 13.81) 72 9.57 (7.60, 12.06) 1.21 (0.90, 1.64) 0.95 (0.69, 1.31)
Fibromyalgia 303 25.12 (22.45, 28.11) 108 8.24 (6.82, 9.95) 3.01 (2.42, 3.76) 2.06 (1.60, 2.65)
Osteoarthritis 2,060 6.48 (6.20, 6.76) 1,528 5.02 (4.77, 5.28)
≤1 year 277 6.75 (6.00,7.60) 260 6.34 (5.61, 7.16) 1.07 (0.90, 1.26) 1.02 (0.86, 1.21)
1-<5 years 844 6.36 (5.95, 6.80) 664 5.36 (4.97, 5.78) 1.19 (1.07, 1.31) 1.12 (1.01, 1.24)
≥5-<10 years 629 6.72 (6.22, 7.27) 376 4.46 (4.03, 7.27) 1.51 (1.33, 1.72) 1.35 (1.18, 1.54)
10≥ years 310 6.11 (5.47, 6.83) 228 4.13 (3.63, 4.70) 1.47 (1.24, 1.74) 1.17 (0.98, 1.40)
Rheumatoid Arthritis 165 9.70 (8.32, 11.29) 96 5.52 (4.52, 6.75) 1.72 (1.34, 2.22) 1.59 (1.20, 2.11)
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Table 3: Age-specific risk of self-harm associated with each rheumatological condition




n Incidence rate, per 
10,000 (95% CI)




<45.3 years 131 78 17.63 (14.12, 22.01) 53 15.22 (11.62,19.92) 1.21 (0.85, 1.71) 0.97 (0.68, 1.40)
>= 45.3 years 43 24 5.28 (3.54, 7.88) 19 4.71 (3.00, 7.38) 1.13 (0.62, 2.06) 0.88 (0.46, 1.68)
Fibromyalgia
<46.7 years 282 205 34.72 (30.27, 39.81) 77 12.30 (9.83, 15.37) 2.77 (2.13, 3.61) 2.28 (1.66, 3.13)
>=46.7 years 129 98 15.92 (13.06, 19.40) 31 4.52 (3.18, 6.43) 3.56 (2.38, 5.32) 2.58 (1.67, 3.99)
Osteoarthritis
<64.6 years
≤1 year 380 192 9.36 (8.13, 10.78) 188 8.99 (7.79, 10.37) 1.04 (0.85, 1.27) 1.01 (0.83, 1.24)
1-<5 years 985 561 8.25 (7.59, 8.96) 424 6.53 (5.94, 7.19) 1.26 (1.11, 1.43) 1.18 (1.03, 1.34)
≥5-<10 years 618 393 7.58 (6.86, 8.37) 225 4.73 (6.86, 8.37) 1.60 (1.36, 1.88) 1.34 (1.13, 1.58)
10≥ years 340 194 5.86 (5.09, 6.75) 146 4.06 (3.46, 4.78) 1.43 (1.15, 1.77) 0.99 (0.80, 1.25)
>=64.6 years
≤1 year 157 85 4.14 (3.35, 5.13) 72 3.58 (2.84, 4.51) 1.16 (0.84, 1.58)
1-<5 years 523 283 4.38 (3.89, 4.92) 240 4.07 (3.58, 4.61) 1.07 (0.90, 1.27)
≥5-<10 years 387 236 5.66 (4.98, 6.42) 151 5.66 (4.98, 6.43) 1.38 (1.13, 1.69)
10≥ years 198 116 6.59 (5.49, 7.91) 82 4.26 (3.43, 5.29) 1.55 (1.17, 2.06)
1.22 (1.07, 1.38)Ϯ
Rheumatoid Arthritis
<57.0 years 184 120 13.20 (11.04, 15.79) 64 7.15 (5.60, 9.13) 1.83 (1.35, 2.48) 1.67 (1.18, 2.36)
>=57.0 years 77 45 5.68 (4.24, 7.60) 32 3.79 (2.68, 5.37) 1.50 (0.95, 2.37) 1.52 (0.92, 2.52)
*adjusted for gender, BMI, smoking status, alcohol consumption, anxiety, depression and practice-level deprivation. Bold = statistically significant (p<=0.05). ϮData 
met assumptions for proportionality and therefore stratification by time was not required 
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Table 4: Gender-specific risk of self-harm associated with each rheumatological condition 
*adjusted for age, BMI, smoking status, alcohol consumption, anxiety, depression and practice-level deprivation. Bold = statistically significant (p<=0.05). 
AS = Ankylosing Spondylitis, OA = Osteoarthritis, RA = Rheumatoid Arthritis




n Incidence rate, 
per 10,000 (95% CI)
n Incidence rate, 
per 10,000 (95% CI)
Crude Adjusted*
Ankylosing Spondylitis
Men 71 42 11.59 (8.56, 15.68) 29 9.35 (6.50, 13.45) 1.25 (0.78, 2.01) 1.13 (0.69, 1.84)
Women 103 60 11.23 (8.72, 14.46) 43 9.73 (7.22, 13.12) 1.19 (0.80, 1.77) 0.83 (0.55, 1.27)
Fibromyalgia
Men 48 35 18.34 (13.17, 25.54) 13 6.82 (3.96, 11.74) 2.98 (1.54, 5.75) 2.16 (0.91, 5.13)
Women 363 268 26.39 (23.42, 29.75) 95 8.48 (6.93, 10.37) 3.03 (2.40, 3.83) 2.44 (1.87, 3.18)
Osteoarthritis
Men
≤1 year 209 108 6.50 (5.38, 7.85) 101 6.08 (5.00, 7.39) 1.07 (0.82, 1.40) 1.06 (0.81, 1.40)
1-<5 years 568 320 6.01 (5.38, 6.70) 248 4.94 (4.36, 5.59) 1.22 (1.03, 1.44) 1.18 (0.99, 1.40)
≥5-<10 years 382 240 6.53 (5.76, 7.41) 142 4.17 (3.53, 4.91) 1.57 (1.27, 1.93) 1.42 (1.14, 1.76)
10≥ years 191 114 8.80 (4.83, 6.97) 77 3.50 (2.80, 4.38) 1.66 (1.24, 2.22) 1.34 (0.99, 1.81)
Women
≤1 year 328 169 6.92 (5.96, 8.05) 159 6.51 (5.78, 7.61) 1.06 (0.86, 1.32) 1.08 (0.87, 1.35)
1-<5 years 940 524 6.60 (6.06, 7.19) 416 5.64 (5.13, 6.21) 1.17 (1.03, 1.33) 1.16 (1.02, 1.33)
≥5-<10 years 623 389 6.85 (6.20, 7.56) 234 4.65 (4.09, 5.29) 1.47 (1.25, 1.73) 1.35 (1.14, 1.59)
10≥ years 347 196 6.31 (5.49, 7.26) 151 4.55 (3.88, 5.33) 1.37 (1.11, 1.70) 1.07 (0.85, 1.34)
Rheumatoid Arthritis
Men 82 53 9.81 (7.50, 12.84) 29 5.03 (3.49, 7.23) 1.89 (1.20, 2.99) 1.63 (0.98, 2.68)
Women 179 112 9.64 (8.01, 11.60) 67 5.77 (4.54, 7.33) 1.65 (1.22, 2.23) 1.56 (1.11, 2.20)










Figure 1 legend: Incidence rates per 10,000 person-years for osteoarthritis (OA), fibromyalgia (FM), rheumatoid arthritis (RA) and ankylosing spondylitis (AS). Solid line 
= rate, dashed line = 95% confidence intervals, lower and upper bands 
